GlassScriptPhysician profile
George T Nahhas
NPI 1427084805
$8,363.95
in general payments reported to CMS, 2019-2025
48 companies · $1,680 in 2025
The $1,680 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $520 · 2021: $1,458 · 2022: $1,581 · 2023: $1,640 · 2024: $804 · 2025: $1,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,722 · Travel and Lodging: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,721.76 |
| Travel and Lodging | $401.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,323.73 | 2019-2025 | Avvigo Guidance System, Synergy, Rotapro |
| Medtronic, INC. | $1,190.03 | 2022-2024 | Micra, V-Loc 180 |
| Janssen Pharmaceuticals, INC | $485.17 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $468.11 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $432.17 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $421.83 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $361.37 | 2019-2025 | Wainua, Farxiga |
| Novartis Pharmaceuticals Corporation | $336.71 | 2019-2025 | |
| Amgen INC. | $296.82 | 2020-2025 | Repatha |
| Merck Sharp & Dohme LLC | $294.65 | 2021-2025 | Verquvo |
| Pfizer INC. | $282.87 | 2019-2025 | |
| Philips North America LLC | $231.54 | 2025 | Igt Devices Undivided, IV Other, Extended Holter |
| Novo Nordisk INC | $194.82 | 2023-2025 | Wegovy, Ozempic |
| Astellas Pharma US INC | $169.98 | 2021 | |
| Cathworks, INC. | $169.35 | 2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $157.59 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $121.60 | 2021 | |
| Cardiovascular Systems INC. | $118.65 | 2019-2021 | |
| Chiesi USA, INC. | $111.83 | 2020-2025 | Kengreal, Cleviprex |
| Truvic Medical, INC. | $100.00 | 2022 | |
| Terumo Medical Corporation | $100.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.42 | 2021-2024 | |
| Amarin Pharma, INC. | $83.70 | 2021-2022 | |
| Cordis US Corp. | $75.37 | 2022-2024 | Saber, Mynxgrip, Zephyr |
| Penumbra, INC. | $71.56 | 2023-2025 | Indigo System, Ruby Coil |
| Abbott Laboratories | $60.55 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Cardiva Medical, INC. | $57.45 | 2023 | Cardiva Vascade 6/7f Vcs |
| Imperative Care, INC | $50.18 | 2024 | Prodigy Catheter |
| Cardinal Health 200 LLC | $46.40 | 2021 | |
| Asahi Intecc USA, INC. | $41.34 | 2022 | |
| Sanofi-Aventis U.S. LLC | $39.94 | 2021 | |
| Bridgebio Pharma, INC. | $39.77 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $38.32 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $35.87 | 2025 | Amvuttra |
| Shockwave Medical, INC | $27.31 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $25.95 | 2024 | Arcalyst |
| Zoll Circulation INC | $22.59 | 2020-2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Glaxosmithkline, LLC. | $21.81 | 2025 | Arexvy |
| Heartflow, INC. | $21.41 | 2023 | Ffrct |
| Reflow Medical INC | $20.22 | 2024 | |
| Vital Connect, INC | $18.29 | 2025 | Vitalpatch Rtm |
| Angiodynamics, INC. | $18.27 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $17.92 | 2025 | Rhythm Express |
| Bsn Medical INC | $17.10 | 2022 | |
| Baxter Healthcare | $15.45 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Avinger INC. | $14.33 | 2019 | |
| Bardy Diagnostics, INC. | $14.31 | 2021 | |
| Ekos Corporation | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Nahhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.